Preferred Label : Genetic Target;
NCIt related terms : geneticTarget;
NCIt definition : The nucleotide or amino acid within the genetic location of interest that is to be
compared to the subject's test result. (BRIDG);
NCI Metathesaurus CUI : CL977678;
Origin ID : C164534;
UMLS CUI : C5236345;
Semantic type(s)
- concept_is_in_subset
https://www.has-sante.fr/jcms/p_3536272/fr/principes-d-evaluation-des-actes-de-sequencage-haut-debit-cible-panels-de-genes-en-genetique-somatique-des-cancers
2024
France
health technology assessment
genes
genes, neoplasm
Genetic Target
evaluation studies as topic
sequence analysis
Assay Target Antigen
policy
Nucleic Acid Sequencing
genetics
High Level
gene, nos
Value Above Reference Range
IPSS-R Risk Category High
Biopolymer Sequencing
principle-based ethics
Backflow
Somatic
IPSS Risk Category High
sequence determinations
High-Frequency Microsatellite Instability
High Mitosis-Karyorrhexis Index
Topical Dosage Form
Panel Device
Topical Route of Administration
Output
Gene
---
https://www.has-sante.fr/jcms/p_3536496/fr/activite-du-sequencage-haut-debit-cible-en-genetique-somatique-des-cancers-financee-dans-le-cadre-du-rihn
2024
France
technical report
High Level
Somatic
Genetic Target
Nucleic Acid Sequencing
CDISC SDTM Environmental Setting Terminology
Topical Route of Administration
Funding
sequence analysis
IPSS-R Risk Category High
High Mitosis-Karyorrhexis Index
gene, nos
Backflow
Active
IPSS Risk Category High
Output
Biopolymer Sequencing
Value Above Reference Range
High-Frequency Microsatellite Instability
sequence determinations
Topical Dosage Form
genetics
Biochemical Activity
financial support
FDA Establishment Activity Terminology
---
https://www.has-sante.fr/jcms/p_3536492/fr/activite-du-sequencage-haut-debit-cible-en-genetique-somatique-des-cancers-financee-dans-le-cadre-du-rihn-programme-des-evaluations-des-actes-de-sequencage-haut-debit-cible
2024
France
health technology assessment
sequence analysis
FDA Establishment Activity Terminology
Biochemical Activity
Somatic
Active
Topical Route of Administration
Scheduled
Assay Target Antigen
financial support
gene, nos
IPSS Risk Category High
Genetic Target
Schedule
Value Above Reference Range
Backflow
Topical Dosage Form
IPSS-R Risk Category High
Biopolymer Sequencing
program evaluation
High Mitosis-Karyorrhexis Index
Nucleic Acid Sequencing
sequence determinations
genetics
High Level
High-Frequency Microsatellite Instability
Funding
Output
CDISC SDTM Environmental Setting Terminology
---
